Feedback PLC Result of Annual General Meeting - Amendment (5643E)
07 November 2020 - 2:03AM
UK Regulatory
TIDMFDBK
RNS Number : 5643E
Feedback PLC
06 November 2020
The following amendments have been made to the 'Result of Annual
General Meeting' announcement released on 5 November 2020 at 1.23
pm under RNS No 4187E.
The 'Total Votes Cast' column in the table below has been
updated to show the correct figures. All other details remain
unchanged. The full amended text is shown below.
Feedback plc
Result of Annual General Meeting - Amendment
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the
specialist medical imaging technology company, announces that at
its annual general meeting held earlier today, all resolutions were
duly passed on a poll. The proxy voting results of the resolutions
are included below.
Resolutions Votes For* % of Votes % of votes Votes Total votes
votes Against cast** Withheld** cast**
cast**
1. To receive
and adopt the
annual report
and accounts for
the year ended
31 May 2020 504,134,927 100.00% - 0.00% 22,000 504,134,927
------------ -------- ---------- ----------- ------------ -----------
2. To elect Adam
Denning as a director 504,152,622 100.00% 3,305 0.00% 1,000 504,155,927
------------ -------- ---------- ----------- ------------ -----------
3. To elect Philipp
Prince as a director 479,902,622 95.19% 24,253,305 4.81% 1,000 504,155,927
------------ -------- ---------- ----------- ------------ -----------
4. To re-elect
Simon Sturge as
a director 504,152,486 100.00% 3,441 0.00% 1,000 504,155,927
------------ -------- ---------- ----------- ------------ -----------
5. To appoint
Price Bailey LLP
as auditors of
the Company 504,118,963 99.99% 36,964 0.01% 1,000 504,155,927
------------ -------- ---------- ----------- ------------ -----------
6. To authorise
the directors
to allot relevant
securities equivalent
to up to two thirds
of the Company's
issued share capital,
subject to certain
conditions 504,027,372 100.00% 3,305 0.00% 126,250 504,030,677
------------ -------- ---------- ----------- ------------ -----------
7. To authorise
the directors
to allot relevant
securities equivalent
to up to 10 per
cent. of the Company's
issued share capital
on a non-pre-emptive
basis subject
to certain conditions 478,945,731 95.01% 25,135,091 4.99% 76,205 504,080,822
------------ -------- ---------- ----------- ------------ -----------
Notes:
* "Votes For" include votes giving the Chairman discretion.
** "Votes Withheld" are not votes in law and do not count in the
number of votes counted for or against a resolution, or towards the
total votes cast.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint
Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited
(Joint Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS")-based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGGZMGMKVGGGZM
(END) Dow Jones Newswires
November 06, 2020 10:03 ET (15:03 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Apr 2024 to May 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From May 2023 to May 2024